Cargando…
The next-generation sphingosine-1 receptor modulator BAF312 (siponimod) improves cortical network functionality in focal autoimmune encephalomyelitis
Autoimmune diseases of the central nervous system (CNS) like multiple sclerosis (MS) are characterized by inflammation and demyelinated lesions in white and grey matter regions. While inflammation is present at all stages of MS, it is more pronounced in the relapsing forms of the disease, whereas pr...
Autores principales: | Hundehege, Petra, Cerina, Manuela, Eichler, Susann, Thomas, Christian, Herrmann, Alexander M., Göbel, Kerstin, Müntefering, Thomas, Fernandez-Orth, Juncal, Bock, Stefanie, Narayanan, Venu, Budde, Thomas, Speckmann, Erwin-Josef, Wiendl, Heinz, Schubart, Anna, Ruck, Tobias, Meuth, Sven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676873/ https://www.ncbi.nlm.nih.gov/pubmed/31290453 http://dx.doi.org/10.4103/1673-5374.259622 |
Ejemplares similares
-
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis
por: Gentile, Antonietta, et al.
Publicado: (2016) -
Siponimod (BAF312) penetrates, distributes, and acts in the central nervous system: Preclinical insights
por: Bigaud, Marc, et al.
Publicado: (2021) -
The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures
por: O’Sullivan, Catherine, et al.
Publicado: (2016) -
Lymphocyte-Related Immunomodulatory Therapy with Siponimod (BAF-312) Improves Outcomes in Mice with Acute Intracerebral Hemorrhage
por: Zhang, Zhiying, et al.
Publicado: (2023) -
Siponimod (BAF312) Activates Nrf2 While Hampering NFκB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration
por: Colombo, Emanuela, et al.
Publicado: (2020)